| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $119.6M | +5.2% |
| Cost of Revenue | $59.2M | +26.3% |
| Gross Profit | $60.3M | -9.6% |
| R&D Expense | $21.7M | +36.1% |
| SG&A Expense | $36.3M | +4.3% |
| Operating Income | -$83.2M | +11.5% |
| Pre-tax Income | -$79.4M | -26.7% |
| Income Tax | $254K | +440.4% |
| Net Income | -$79.7M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $138.5M | -30.1% |
| Accounts Receivable | $9.6M | +74.9% |
| Current Assets | $152.6M | -28.5% |
| Total Assets | $156.3M | -30.1% |
| Current Liabilities | $27.3M | +0.5% |
| Long-term Debt | $300K | — |
| Total Liabilities | $28.7M | -8.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$61.1M | +7.1% |
| Capital Expenditures | $350K | -47.2% |
| Investing Cash Flow | -$317K | +52.2% |
| Financing Cash Flow | $1.7M | -99.3% |
| Free Cash Flow | -$61.4M | +7.5% |
| -27.0% |
| EPS (Basic) | -$0.51 | +29.2% |
| EPS (Diluted) | -$0.51 | +29.2% |
| Stockholders' Equity |
| $127.5M |
| -33.7% |